Samsung Biologics bags $1.24bn CDMO contract with Asia-based pharma firm
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), has signed its largest-ever contract, valued at USD 1.24 billion, with an undisclosed ... Read More
Samsung Biologics to manufacture Moderna’s mRNA-1273 COVID-19 vaccine
Moderna has signed a manufacturing services and supply agreement with Samsung Biologics under which the latter will undertake large scale, commercial fill-finish manufacturing for the ... Read More